Core Scientific (CORZ) is a digital infrastructure provider specializing in colocation and digital asset mining, with a recent shift towards AI. The company reported Q3 2025 results, posting revenue of $81.1 million, a net loss of $146.7 million, and earnings per share of ($0.46). Despite missing analyst expectations, the company saw growth in high-density colocation services. Roth Capital Partners upgraded Core Scientific to “Buy” from “Neutral” with a target price of $23.50, reflecting optimism about the company’s future. Analysts give CORZ a consensus “Moderate Buy” rating with a mean target price of $20.67.

Read more at Barchart: The CoreWeave-Core Scientific Deal Isn’t Likely to Go Through. Analysts Say That Makes CORZ Stock a Buy.